Published on
​Pharmacology - Enfuvirtide 
Inhibiting HIV entrance into host cells is the action of enfuvirtide.

Functions by attaching to an HIV envelope subunit, which in turn blocks the virus from infecting the mammalian cell by preventing it from fusing with the target cell membrane.

Administered through intravenous injection. The half-life is four hours.

Use in Clinical Settings 
infection with HIV-1 while taking other antiretrovirals (ARTs).

Negative Impacts
Reactions caused by hypersensitivity.
Picture
0 Comments